The impact of a discovery described in Nature Medicine may not alter approaches to attacking HIV, but it may change the way in which therapeutics are evaluated. The findings - which showed that life expectancy of T cells is shortened in infected patients - could facilitate direct measurements of how HIV affects a patient, leading to new ways to measure the potential efficacy of candidate drugs as well as to personalized HIV therapies.

Researchers from the University of